跳至主要内容
临床试验/NCT00033046
NCT00033046Unknown1 期

Safety Evaluation of Cocaine Treatment Medication Modafinil: Interactions With Intravenous Cocaine

National Institute on Drug Abuse (NIDA)2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2001年6月最近更新:
适应症
相关药物

试验速览

阶段
1 期
入组人数
12
试验地点
2
主要终点
pharmacokinetic parmaters at steady state

研究概览

简要总结

The purpose of this study is to evaluate modafinil, a cocaine treatment medication, and its interactions with intravenous (IV) cocaine.

详细描述

Placebo-controlled, escalating dose drug interaction study using a total of 12 cocaine users at a single site. Study duration will include four infusion sessions: 1) screening/baseline; 2) baseline; 3) 400mg/day steady-state modafinil; 4) 800 mg/day steady state modafinil. Infusion session will be 2 days in duration.

研究设计

研究类型
Interventional
干预模型
Crossover
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Dependent on cocaine; non-treatment seeking; male or female; DSM-4 criteria for cocaine abuse or dependence; at least 18 years of age but no older than 45 non-pregnant females using adequate birth control; capable of providing written informed consent; able to comply with protocol requirements.

排除标准

  • Additional criteria available during screening at the site

结局指标

主要结局

pharmacokinetic parmaters at steady state

BP, HR

次要结局

未报告次要终点

研究者

申办方类型
Nih

研究点 (2)

Loading locations...

相似试验